Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07114718 · ClinicalTrials.gov registry record · NA
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
A NA study of Congenital Heart Disease and Congenital Heart Disease (CHD), sponsored by Starlight Cardiovascular.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 7
- Study locations
NCT07114718: Recruiting NA study of Congenital Heart Disease and Congenital Heart Disease (CHD), sponsored by Starlight Cardiovascular.
NCT07114718 is a NA study of Congenital Heart Disease and Congenital Heart Disease (CHD) that is actively recruiting participants, run by Starlight Cardiovascular. The registered enrollment target is 35 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (93% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07114718, a NA study of Congenital Heart Disease and Congenital Heart Disease (CHD), is actively recruiting participants, sponsored by Starlight Cardiovascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 7
- Study locations
Study Summary
Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.
Primary Outcome
Freedom from death related to the device or implantation procedure or Major Complication related to the device or implantation procedure at 30 days.
Conditions Studied
Interventions
- DEVICE Ductus Arteriosus Stent
Study Locations (7)
California
- UCLA Mattel Children's - Los Angeles
- Leland Stanford Junior University - Stanford
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's Hospital - Columbus
Colorado
- Children's Hospital Colorado - Aurora
Massachusetts
- Boston Children's Hospital - Boston
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2028-04 |
| Phase | NA |
What NCT07114718 shows while recruiting
NCT07114718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Ductus Arteriosus Stent is the first listed.
NCT07114718 lists 7 locations in 5 states (California, Ohio, Colorado).
Frequently Asked Questions
What is clinical trial NCT07114718 about?
NCT07114718 is a clinical study titled "Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study". Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that...
What is the current status of trial NCT07114718?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-12-03. Estimated completion is 2028-04.
What conditions does trial NCT07114718 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Congenital Heart Disease (CHD).
What interventions are being tested in trial NCT07114718?
The interventions under investigation include: Ductus Arteriosus Stent (DEVICE).
Who is sponsoring clinical trial NCT07114718?
This trial is sponsored by Starlight Cardiovascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07114718 being conducted?
This trial has 7 study locations across California, Colorado, Massachusetts, Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07114718's enrollment target sits among peer trials
35 54th of 63 higher than 10 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
-
Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI